CompanyGraph
Zhejiang Jiahua Energy Chemical Industry Co., Ltd.
600273 · SSE · China
jhec.com.cnFinancials as of FY2025
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleMarket cap is $1.33B, above the global median of $1.15B
- PositionP/E ratio is 11.05×, lower than 95% of its Specialty Chemicals peers (median 42.43×)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
7.32%Above 5Y avg (5.84%)
Annual Rate
CNY 0.50Paid semi-annual
Payout Ratio
65.0%Moderate
Payback Period
15.0 yr
Last Ex-Dividend
May 25, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.96BCNY1.33B · vs all stocks (USD)
Trailing P/E
11.05xvs Specialty Chemicals peers
Revenue (TTM)
10.46BCNY1.55B · vs all stocks (USD)
Profit Margin
7.80%vs Specialty Chemicals peers
Beta
0.4680xvs all stocks
52-Week Change
-22.82%vs all stocks
Forward Annual Dividend Yield
7.32%vs all stocks
Market Capitalization
8.96BCNY1.33B · vs all stocks (USD)
Enterprise Value
9.31BCNY1.38B · vs all stocks (USD)
Trailing P/E
11.05xvs Specialty Chemicals peers
Forward P/E
7.06xvs Specialty Chemicals peers
Price to Sales (TTM)
0.8590xvs Specialty Chemicals peers
Price to Book (MRQ)
0.8727xvs Specialty Chemicals peers
Enterprise to Revenue
0.8910xvs Specialty Chemicals peers
Enterprise to EBITDA
5.78xvs Specialty Chemicals peers
Gross Margin
10.89%vs Specialty Chemicals peers
Profit Margin
7.80%vs Specialty Chemicals peers
Operating Margin
6.90%vs Specialty Chemicals peers
Return on Assets (TTM)
3.98%vs Specialty Chemicals peers
Return on Equity (TTM)
7.93%vs Specialty Chemicals peers
Revenue (TTM)
10.46BCNY1.55B · vs all stocks (USD)
Revenue per Share (TTM)
7.90CNYUpdated Aug 20, 2026Quarterly Revenue Growth
11.70%vs Specialty Chemicals peers
Gross Profit (TTM)
1.33BCNY197.95M · vs all stocks (USD)
EBITDA (TTM)
1.12BCNY166.51M · vs all stocks (USD)
Net Income (TTM)
815.48MCNY121.12M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-62.50%vs Specialty Chemicals peers
Operating Cash Flow (TTM)
935.71MCNY138.97M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
782.95MCNY116.28M · vs all stocks (USD)
Forward Annual Dividend Rate
0.5000CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
7.32%vs all stocks
Trailing Annual Dividend Rate
0.4500CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
6.59%vs all stocks
5-Year Average Dividend Yield
5.84%vs all stocks
Payout Ratio
65.00%vs Specialty Chemicals peers
Minority Interest (Equity)
7.03MCNYFY2025 · Dec 31, 2025Revenue
10.18BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
8.67BCNYFY2025 · Dec 31, 2025Gross Profit
1.51BCNYFY2025 · Dec 31, 2025Operating Income
1.06BCNY157.43M · vs all stocks (USD)
Pre-tax Income
1.12BCNYFY2025 · Dec 31, 2025Income Tax Expense
135.96MCNYFY2025 · Dec 31, 2025Net Income
987.78MCNYFY2025 · Dec 31, 2025EBIT
1.15BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.95BCNYFY2025 · Dec 31, 2025Research & Development
314.36MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
50.91MCNYFY2025 · Dec 31, 2025Other Operating Expenses
38.83MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.23MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
30.42MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.33BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.33BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
987.78MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-23.39KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
845.95MCNYFY2025 · Dec 31, 2025Free Cash Flow
590.51MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.05BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
987.78MCNYFY2025 · Dec 31, 2025Other Non-cash Items
68.07MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-277.30MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
67.40MCNYFY2025 · Dec 31, 2025Capital Expenditures
-255.44MCNYFY2025 · Dec 31, 2025Purchase of Investments
-22.93MCNYFY2025 · Dec 31, 2025Sale of Investments
15.42MCNYFY2025 · Dec 31, 2025Other Investing Activity
82.50MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-180.45MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.71BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.11BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-570.26MCNYFY2025 · Dec 31, 2025Other Financing Charges
-406.87MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-377.94MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.31BSharesUpdated Aug 20, 2026Float Shares
691.45MSharesUpdated Aug 20, 2026% Held by Insiders
41.47%vs all stocks
% Held by Institutions
11.15%vs all stocks
Total Cash (MRQ)
1.24BCNY183.65M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.9540CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.64BCNY244.24M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1614xvs Specialty Chemicals peers
Current Ratio (MRQ)
1.71xvs Specialty Chemicals peers
Book Value per Share (MRQ)
7.85CNYUpdated Aug 20, 2026Total Assets
13.33BCNY1.98B · vs all stocks (USD)
Total Current Assets
3.81BCNYFY2025 · Dec 31, 2025Total Liabilities
3.15BCNYFY2025 · Dec 31, 2025Total Non-current Assets
9.51BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.02BCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.13BCNYFY2025 · Dec 31, 2025Cash
674.31MCNYFY2025 · Dec 31, 2025Cash Equivalents
438.48MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.11BCNYFY2025 · Dec 31, 2025Accounts Receivable
788.71MCNYFY2025 · Dec 31, 2025Inventory
682.27MCNYFY2025 · Dec 31, 2025Accounts Payable
419.89MCNYFY2025 · Dec 31, 2025Short-term Debt
727.86MCNYFY2025 · Dec 31, 2025Other Current Liabilities
10.29MCNYFY2025 · Dec 31, 2025Long-term Debt
766.44MCNYFY2025 · Dec 31, 2025Retained Earnings
6.66BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
10.18BCNY1.51B · vs all stocks (USD)
Treasury Stock
428.65MCNYFY2025 · Dec 31, 202552-Week Low
6.33CNYUpdated Aug 20, 202652-Week High
12.25CNYUpdated Aug 20, 202652-Week Change
-22.82%vs all stocks
Beta
0.4680xvs all stocks
50-Day MA
6.80CNYUpdated Aug 20, 2026200-Day MA
8.66CNYUpdated Aug 20, 2026Avg 10-Day Volume
14.69MSharesUpdated Aug 20, 2026Avg 30-Day Volume
16.90MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.6200CNYUpdated Aug 20, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
Where is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 11.05×, lower than 95% of its Specialty Chemicals peers (median 42.43×)Notable
P/E ratio: 11.05Industry median: 42.43Industry P5: 15.33Peers compared: 144
Price-to-book is 0.87×, lower than 95% of its Specialty Chemicals peers (median 2.68×)Notable
Price-to-book: 0.87Industry median: 2.68Industry P5: 0.97Peers compared: 144
Financial Health
Altman Z-Score 3.61: safe zoneNotable
Altman Z-Score: 3.61
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Market cap is $1.33B, above the global median of $1.15BNotable
Market cap (USD): 1,330,180,958.322Global Median: 1,146,734,693.424
Revenue is $1.55B, above the global median of $520.53MNotable
Revenue (USD): 1,553,018,423.828Global Median: 520,528,949.311
Levered free cash flow is $116.28M, above the global median of $16.24MNotable
Levered free cash flow (USD): 116,283,869.45Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Kraken Robotics Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Camel Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Stepan Company
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
NWPX Infrastructure, Inc.
Tier 1ProductionThroughput-Bound ConversionFlow
Bittium Oyj
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shaily Engineering Plastics Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Scientex Berhad
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sanfeng Intelligent Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wuxi DK Electronic Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Lloyds Engineering Works Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Jyothy Labs Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityIndustry-Benchmarked Return on Capital Elevated
Xiamen Amoytop Biotech Co., Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityIndustry-Benchmarked Return on Capital Elevated
Stride, Inc.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityIndustry-Benchmarked Return on Capital Elevated
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.